News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
619,571 Results
Type
Article (47673)
Company Profile (221)
Press Release (571677)
Section
Business (177322)
Career Advice (2588)
Deals (32647)
Drug Delivery (117)
Drug Development (79026)
Employer Resources (161)
FDA (16288)
Job Trends (13637)
News (313966)
Policy (32480)
Tag
Academia (2409)
Alliances (44851)
Alzheimer's disease (1375)
Approvals (16225)
Artificial intelligence (193)
Bankruptcy (321)
Best Places to Work (10193)
Biotechnology (115)
Breast cancer (214)
Cancer (1608)
Cardiovascular disease (131)
Career advice (2155)
CAR-T (118)
Cell therapy (339)
Clinical research (63567)
Collaboration (596)
Compensation (338)
COVID-19 (2641)
C-suite (143)
Data (1470)
Diabetes (205)
Diagnostics (5547)
Earnings (69132)
Employer resources (146)
Events (93590)
Executive appointments (520)
FDA (17121)
Funding (508)
Gene therapy (240)
GLP-1 (736)
Government (3989)
Healthcare (15988)
Infectious disease (2749)
Inflammatory bowel disease (118)
Interviews (471)
IPO (15295)
Job creations (3861)
Job search strategy (1812)
Layoffs (485)
Legal (7853)
Lung cancer (245)
Manufacturing (239)
Medical device (11511)
Medtech (11515)
Mergers & acquisitions (17667)
Metabolic disorders (587)
Neuroscience (1794)
NextGen: Class of 2025 (5529)
Non-profit (3436)
Northern California (1870)
Obesity (341)
Opinion (242)
Parkinson's disease (118)
Patents (142)
People (52001)
Phase I (19580)
Phase II (27624)
Phase III (21515)
Pipeline (662)
Postmarket research (2610)
Preclinical (7926)
Radiopharmaceuticals (237)
Rare diseases (319)
Real estate (5405)
Regulatory (22368)
Research institute (2225)
Resumes & cover letters (427)
Southern California (1589)
Startups (3333)
United States (16480)
Vaccines (680)
Weight loss (261)
Date
Today (144)
Last 7 days (617)
Last 30 days (2771)
Last 365 days (33522)
2025 (2905)
2024 (33914)
2023 (37973)
2022 (48622)
2021 (52398)
2020 (49776)
2019 (40612)
2018 (31005)
2017 (31309)
2016 (30111)
2015 (33776)
2014 (27447)
2013 (23079)
2012 (24736)
2011 (25346)
2010 (23294)
Location
Africa (786)
Arizona (167)
Asia (38718)
Australia (6417)
California (4221)
Canada (1417)
China (352)
Colorado (198)
Connecticut (220)
Europe (87193)
Florida (625)
Georgia (138)
Illinois (394)
Indiana (217)
Maryland (695)
Massachusetts (3339)
Michigan (158)
Minnesota (289)
New Jersey (1223)
New York (1194)
North Carolina (800)
Northern California (1870)
Ohio (143)
Pennsylvania (953)
South America (1163)
Southern California (1589)
Texas (601)
Washington State (424)
619,571 Results for "zealand pharma a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Complete response letters
Zealand Hit With CRL for Ultrarare Genetic Disease Treatment
The rejection is related to the timing of the FDA’s reinspection of Zealand’s third-party manufacturer, which previously had deficiencies.
October 9, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity
January 8, 2025
·
2 min read
Press Releases
Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th
January 7, 2025
·
1 min read
Business
Zealand Pharma Announces Financial Results for the First Quarter of 2024
Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced the interim report for the three months ended March 31, 2024, and provided a corporate update.
May 16, 2024
·
10 min read
Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024
Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that Adam Steensberg, President and CEO, will participate in fireside chats at the following healthcare investor conferences in June.
May 29, 2024
·
1 min read
Drug Development
Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
June 7, 2024
·
7 min read
Press Releases
Zealand Pharma to participate in the 2024 Jefferies London Healthcare Conference
November 14, 2024
·
1 min read
Press Releases
Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism
October 9, 2024
·
8 min read
Drug Development
Boehringer, Zealand’s GLP-1 MASH Data ‘Unintentionally’ Published by Medical Congress Website
Zealand Pharma said on Thursday that partner Boehringer Ingelheim will present the results from the study on Friday at the European Association of the Study of Liver Congress.
June 6, 2024
·
2 min read
·
Nick Paul Taylor
Drug Development
Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASL
Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASL
June 6, 2024
·
6 min read
1 of 61,958
Next
